Brown Advisory Inc. filed a Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 3,960,468 shares of Bioventus Inc. Class A Common Stock as of September 30, 2026, representing 5.80% of the class.

Key Highlights

  • Aggregate beneficial ownership: Brown Advisory Inc. reported beneficial ownership of 3,960,468 shares of Bioventus Class A Common Stock, equal to 5.80% of the class.
  • Sole voting power: Brown Advisory Inc. holds sole voting power over 3,797,325 shares; its subsidiary Brown Advisory LLC holds sole voting power over 3,743,186 shares.
  • Shared dispositive power: Brown Advisory Inc. holds shared dispositive power over 3,957,057 shares, with zero sole dispositive power reported.
  • Four subsidiaries involved: The filing covers Brown Advisory Inc. and four subsidiaries: Brown Investment Advisory & Trust Co., Brown Advisory LLC, Signature Financial Management, Inc., and Brown Advisory Ltd.
  • Triggering event date: The event requiring this filing occurred on September 30, 2026.
  • Ordinary course certification: The filing certifies the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Brown Advisory's Reported Holdings in Bioventus Class A Shares

According to the Schedule 13G filed November 13, 2026, Brown Advisory Inc., a Maryland parent holding company, reported aggregate beneficial ownership of 3,960,468 shares of Bioventus Inc. (NASDAQ:BVS) Class A Common Stock, par value $0.001 per share (CUSIP 09075A108). The filing lists the triggering event date as September 30, 2026. Brown Advisory Inc. reported sole voting power over 3,797,325 shares and shared dispositive power over 3,957,057 shares, with no sole dispositive power and no shared voting power reported at the parent level.

The filing covers four subsidiaries of Brown Advisory Inc. Brown Advisory LLC, organized in Maryland and classified as an investment adviser, reported beneficial ownership of 3,906,329 shares, representing 5.72% of the class, with sole voting power over 3,743,186 shares and shared dispositive power over 3,906,329 shares. Brown Investment Advisory & Trust Co., a Maryland bank, reported beneficial ownership of 48,503 shares (0.07% of the class), with sole voting power over 48,503 shares and shared dispositive power over 45,092 shares. Signature Financial Management, Inc., a Virginia investment adviser, and Brown Advisory Ltd, a United Kingdom investment adviser, reported beneficial ownership of 2,375 shares and 3,261 shares, respectively, each representing 0% of the class as stated in the filing.

The filing states that "the total securities being reported are beneficially owned by investment companies and other managed accounts of direct/indirect subsidiaries of Brown Advisory Inc." and that applicable investment advisory contracts provide voting and/or investment power over the securities. Brown Advisory Inc. is identified as the parent holding company filing pursuant to Rule 13d-1(b)(1)(ii)(G) of the Securities Exchange Act of 1934. The filers are based at 901 South Bond Street, Suite #400, Baltimore, Maryland 21231.

What Was Disclosed

Brown Advisory Inc. and four affiliated entities disclosed a combined 5.80% beneficial ownership stake in Bioventus Inc. Class A Common Stock via a Schedule 13G, with the triggering event dated September 30, 2026, and the filing submitted November 13, 2026.